cancer

Indian plant compound gedunin kills cancer cells, new research finds

Sunday, February 24, 2013 by: J. D. Heyes
Tags: cancer cells, plant medicine, Hsp90

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
Biologist explains how marijuana causes tumor cells to commit suicide
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
Companies begin planting microchips under employees' skin
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
Chemotherapy kills cancer patients faster than no treatment at all
Why flu shots are the greatest medical fraud in history
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
Flu vaccine kills 13 in Italy; death toll rises
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Whooping cough outbreak at Massachusetts high school affected only vaccinated students

Delicious
(NaturalNews) Researchers at the Georgia Regents University Cancer Center have identified an India-based plant which has been used for centuries to treat inflammation, fever and malaria that could be used to help kill cancer cells.

Dr. Ahmed Chadli, a researcher in the Molecular Chaperone Program at the GRU Cancer Center and senior author of the study named the Journal of Biological Chemistry's "Paper of the Week," said cancer cells typically survive by hijacking so-called molecular chaperones that in turn guide and protect the proteins that ensure normal cellular function, then tricking them into assisting mutated versions of those proteins to stay alive, according to a press release published by the university.

Therefore, development of drugs has focused largely on the chaperone Hsp90 (heat shock protein 90) "because it plays a key role in assisting mutating proteins, making it an attractive cancer drug target," the release said.

'In the future, this research could have applications in other cancers'

But the clinical efficacy of Hsp90 inhibitors has been less than stellar; most current small molecules that target Hsp90 have inadvertently resulted in the expression of proteins that protect cancerous cells from cell death, thereby compromising the Hsp90 inhibitors in the clinical setting.

In the current study; however, Chaitanya Patwardhad, a graduate student in Dr. Chadli's laboratory, discovered that gedunin, an Indian plant compound, attacks a helper protein, or co-chaperone, of Hsp90 known as p23.

"This compound binds directly to p23, leading to inactivation of the Hsp90 machine - without production of anti-apoptotic proteins - thus killing cancer cells," said Chadli. "The idea here is that this will open a door for new ways of targeting Hsp90 by targeting its helper proteins, which may be used in combination with established Hsp90 inhibitors that are ongoing clinical trials."

"In the future, this research could have applications in drug development for hormone-dependent cancers, including breast, prostate and endometrial cancers," he said.

"One of the major areas of scientific emphasis of the GRU Cancer Center is to develop therapeutic approaches to cancer targeting specific molecules within the cancer cell, including chaperones," added Dr. Samir N. Khleif, director of the GRU Cancer Center. "This finding is an important piece of the puzzle, bringing us closer to our goal of helping patients with cancer."

Gedunin, according to Santa Cruz Biotechnology, Inc., "is a naturally occurring Hsp90 inhibitor. In vitro, Gedunin induces Hsp90-dependent client protein degradation and displays antiproliferative activity."

It is obtained from the Indian neem tree and has been used for centuries in Asia as a natural remedy for malaria. It has also been used as an insecticidal and, most recently, as an anti-cancer agent.

Gedunin may be useful in treatment of neurological disorders too

In 2009, researchers found a nearly 80 percent decrease in the cell proliferation in ovarian cancer cells after in-vitro treatment with gedunin. (http://saypeople.com)

A separate study by Emory University found that gedunin and its derivatives looked promising in the treatment of Parkinson's disease, Alzheimer's disease, HIV-related dementia, multiple sclerosis, amyotrophic lateral sclerosis, stroke, and Huntington's disease.

As for Chadli, he says that this research could have applications in drug development for hormone-dependent cancers, including breast, prostate, and endometrial cancers.

Sources:

http://www.eurekalert.org/pub_releases/2013-02/ghsu-ipc021413.php

http://www.scbt.com/datasheet-203967-gedunin.html

http://saypeople.com

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.